| # | Title | Journal | Year | Citations |
|---|
| 1 | Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors | JAMA Oncology | 2018 | 1,625 |
| 2 | Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis | Lancet, The | 2018 | 618 |
| 3 | Fibromuscular dysplasia | Orphanet Journal of Rare Diseases | 2007 | 245 |
| 4 | Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis | European Journal of Cancer | 2010 | 195 |
| 5 | Clinical Events as a Function of Proton Pump Inhibitor Use, Clopidogrel Use, and Cytochrome P450 2C19 Genotype in a Large Nationwide Cohort of Acute Myocardial Infarction | Circulation | 2011 | 140 |
| 6 | Hematologic Complications of Immune Checkpoint Inhibitors | Oncologist | 2019 | 103 |
| 7 | Microbiome and metabolome features of the cardiometabolic disease spectrum | Nature Medicine | 2022 | 102 |
| 8 | Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget’s disease of bone and frontotemporal dementia | Neuromuscular Disorders | 2009 | 79 |
| 9 | Risk Assessment for Severe Clinical Attachment Loss in an Adult Population | Journal of Periodontology | 2006 | 75 |
| 10 | Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort | Alimentary Pharmacology and Therapeutics | 2011 | 55 |
| 11 | Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database | Annals of the Rheumatic Diseases | 2019 | 54 |
| 12 | Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism | Gut | 2022 | 53 |
| 13 | Dopa-decarboxylase gene polymorphisms affect the motor response to l-dopa in Parkinson's disease | Parkinsonism and Related Disorders | 2014 | 50 |
| 14 | Efficacy of ibrutinib in the treatment of Bing–Neel syndrome | American Journal of Hematology | 2016 | 48 |
| 15 | Comprehensive efforts to increase adherence to statin therapy | European Heart Journal | 2017 | 40 |
| 16 | Cardiac performance in patients hospitalized with COVID‐19: a 6 month follow‐up study | ESC Heart Failure | 2021 | 40 |
| 17 | Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis | Cancer Discovery | 2023 | 40 |
| 18 | Demographic Factors Associated with Toxicity in Patients Treated with Anti–Programmed Cell Death-1 Therapy | Cancer Immunology Research | 2020 | 37 |
| 19 | Simultaneous determination of rivaroxaban and dabigatran levels in human plasma by high-performance liquid chromatography–tandem mass spectrometry | Journal of Pharmaceutical and Biomedical Analysis | 2014 | 32 |
| 20 | HLA-associated drug hypersensitivity and the prediction of adverse drug reactions | Pharmacogenomics | 2017 | 29 |
| 21 | Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward | Autoimmunity Reviews | 2021 | 26 |
| 22 | Characterization of auto-immune hepatitis associated with the use of anti-TNFα agents: An analysis of 389 cases in VigiBase | Autoimmunity Reviews | 2020 | 21 |
| 23 | Quinine Pharmacokinetics and Pharmacodynamics in Children with Malaria Caused by Plasmodium falciparum | Antimicrobial Agents and Chemotherapy | 2005 | 19 |
| 24 | Determination of Colistin and Colistimethate Levels in Human Plasma and Urine by High-Performance Liquid Chromatography–Tandem Mass Spectrometry | Therapeutic Drug Monitoring | 2016 | 19 |
| 25 | Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case–noncase study | Kidney International | 2021 | 19 |
| 26 | Low Central Nervous System Posaconazole Concentrations during Cerebral Phaeohyphomycosis | Antimicrobial Agents and Chemotherapy | 2019 | 18 |
| 27 | Type 2 Diabetes Mellitus Is Independently Associated With Decreased Neural Baroreflex Sensitivity | Arteriosclerosis, Thrombosis, and Vascular Biology | 2020 | 18 |
| 28 | Sclerodermiform aspect of arm lymphoedema after treatment with docetaxel for breast cancer | Journal of the European Academy of Dermatology and Venereology | 2007 | 17 |
| 29 | Drug‐induced aseptic meningitis: 329 cases from the French pharmacovigilance database analysis | British Journal of Clinical Pharmacology | 2019 | 17 |
| 30 | Increased reporting of fatal hepatitis associated with immune checkpoint inhibitors | European Journal of Cancer | 2019 | 17 |
| 31 | Development and validation of a UPLC-MS/MS method for simultaneous quantification of levofloxacin, ciprofloxacin, moxifloxacin and rifampicin in human plasma: Application to the therapeutic drug monitoring in osteoarticular infections | Journal of Pharmaceutical and Biomedical Analysis | 2020 | 15 |
| 32 | Response to the editorial “COVID-19 in patients with cardiovascular diseases” | Archives of Cardiovascular Diseases | 2020 | 15 |
| 33 | Plasma concentrations of atovaquone given to immunocompromised patients to prevent Pneumocystis jirovecii | Journal of Antimicrobial Chemotherapy | 2017 | 14 |
| 34 | Prevention of Invasive Aspergillus Fungal Infections with the Suspension and Delayed-Release Tablet Formulations of Posaconazole in Patients with Haematologic Malignancies | Scientific Reports | 2018 | 14 |
| 35 | Sevoflurane for procedural sedation in critically ill patients: A pharmacokinetic comparative study between burn and non-burn patients | Anaesthesia, Critical Care & Pain Medicine | 2018 | 14 |
| 36 | Development and Validation of a Fast Ultra-High Performance Liquid Chromatography–Fluorescent Method for the Quantification of Hydroxychloroquine and Its Metabolites in Patients With Lupus | Therapeutic Drug Monitoring | 2019 | 14 |
| 37 | Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors | Lung Cancer | 2021 | 14 |
| 38 | Non-Hemodynamically Significant Renal Artery Stenosis Predicts Cardiovascular Events in Persons with Ischemic Heart Disease | American Journal of Nephrology | 2014 | 13 |
| 39 | Clinical pharmacology of anti-angiogenic drugs in oncology | Critical Reviews in Oncology/Hematology | 2017 | 13 |
| 40 | Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method | Scientific Reports | 2019 | 13 |
| 41 | Increased mortality risk in diabetic patients discharged from hospital with insulin therapy after an acute myocardial infarction: Data from the FAST-MI 2005 registry | European Heart Journal: Acute Cardiovascular Care | 2019 | 13 |
| 42 | Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies | Journal of Neurology, Neurosurgery and Psychiatry | 2020 | 13 |
| 43 | The functional dlt operon of Clostridium butyricum controls the d-alanylation of cell wall components and influences cell septation and vancomycin-induced lysis | Anaerobe | 2015 | 12 |
| 44 | Effects of Dihydroartemisinin-Piperaquine Phosphate and Artemether-Lumefantrine on QTc Interval Prolongation | Scientific Reports | 2019 | 12 |
| 45 | Major pitfalls of protein kinase inhibitors prescription: A review of their clinical pharmacology for daily use | Critical Reviews in Oncology/Hematology | 2019 | 11 |
| 46 | Early central blood pressure elevation in adult patients with 21-hydroxylase deficiency | Journal of Hypertension | 2019 | 10 |
| 47 | Life-Saving, Dose-Adjusted, Targeted Therapy in a Patient with a STAT3 Gain-of-Function Mutation | Journal of Clinical Immunology | 2021 | 10 |
| 48 | c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children – A c4c expert group white paper | British Journal of Clinical Pharmacology | 2022 | 8 |
| 49 | Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients with Atrial Tachyarrhythmias | Clinical Pharmacokinetics | 2016 | 7 |
| 50 | Reporting of immune checkpoint inhibitor-associated myocarditis – Authors' reply | Lancet, The | 2018 | 7 |
